DermaXon

DermaXon

Biotechnology

Missoula, Montana 323 followers

Further exploring the brain-skin connection for a better life.

About us

DermaXon targets the brain-skin connection to discover and develop novel therapeutic strategies to treat life-threatening diseases and disorders such as pain, pruritus and genetic disorders of skin keratinization. The company core technology is based on the design and development of small molecules modulating multiple targets or inhibiting the degradation of endogenous molecules exhibiting polypharmacology. This polypharmacological approaches aim to understand and optimize the unknown off-targets activities for existing small molecules such as cannabinoids or retinoic acid. DermaXon uses medicinal chemistry, molecular biology and RNA sequencing to characterize and identify synergies and overlaps between biological signaling pathways modulated by small molecules.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Missoula, Montana
Type
Privately Held
Founded
2013
Specialties
Drug Discovery, Dermatology, Alzheimer's disease, Parkinson's disease, Ichthyosis, Acne, and Aging

Locations

  • Primary

    32 Campus Dr

    DermaXon Laboratory

    Missoula, Montana 59812, US

    Get directions

Employees at DermaXon

Updates

Similar pages

Browse jobs